Page last updated: 2024-11-02

pd 98059 and Diabetic Neuropathies

pd 98059 has been researched along with Diabetic Neuropathies in 1 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Saiki, T1
Nakamura, N1
Miyabe, M1
Ito, M1
Minato, T1
Sango, K1
Matsubara, T1
Naruse, K1

Other Studies

1 other study available for pd 98059 and Diabetic Neuropathies

ArticleYear
The Effects of Insulin on Immortalized Rat Schwann Cells, IFRS1.
    International journal of molecular sciences, 2021, May-23, Volume: 22, Issue:11

    Topics: Animals; Cell Division; Cell Line, Transformed; Chromones; Diabetic Neuropathies; Extracellular Sign

2021